Australian (ASX) Stock Market Forum

LLC - LendLease Group

Lendlease establishes new Asia Pacific life sciences real estate platform with Warburg Pincus

As part of Lendlease’s ongoing simplification, the Group today announced it has agreed to sell its life sciences interests in Asia to a newly established 50/50 joint venture with Warburg Pincus, creating a specialist real estate platform focussed on the growing life sciences sector in Asia Pacific.

The transaction, which provides Lendlease an opportunity to realise the value it has created, will see it transfer its current life sciences construction and development capabilities in Asia, together with its life sciences investments, to the new joint venture entity.

The transaction value of S$129 (A$147) million1 demonstrates Lendlease’s established track record in the region and its ability to source and create future investment opportunities.

The transaction is expected to realise approximately A$66 million in net cash proceeds to Lendlease, and is subject to certain completion adjustments and conditions precedent, including third party consents.

The new real estate platform complements Lendlease’s existing Investments platform in Asia, including both private funds and the listed Lendlease Global Commercial REIT.

Lendlease maintains its FY24 guidance of 7 per cent return on equity.

It is noted that achieving this return remains conditional on execution of a number of transactions, including this transaction and the previously announced sale of 12 Communities projects.

The Communities sale remains subject to regulatory approvals and other conditions precedent. Quotes attributable to Tony Lombardo, Global CEO, Lendlease “With the combination of Lendlease’s 30 year track record in the Asia Pacific supporting the world’s largest pharmaceutical and life sciences companies and Warburg Pincus’s experience and track record in investing and scaling platforms, the joint venture is well-positioned to become the leading integrated life sciences real estate business in the region, offering compelling new investment opportunities to our investors.”

“This is another example of how we’re realising value from our existing operations, while further simplifying Lendlease to create a more focussed company for securityholders.”

1 Transaction price represented on a 100% ownership basis

ends

i hold LLC

let's see if this excites to market ( i doubt it , but have been wrong before )
 
it hit a 12 month low on Friday , one might wonder if and how the proceeds will be used , i hope NOT to boost the salaries of management

am down about 60% on this

they will have to find something impressive to do , to convince me not to crystallize the tax-losses here

there are plenty of external headwinds blowing and this seems to be a self-mutilator to boot
 
it hit a 12 month low on Friday , one might wonder if and how the proceeds will be used , i hope NOT to boost the salaries of management

am down about 60% on this

they will have to find something impressive to do , to convince me not to crystallize the tax-losses here

there are plenty of external headwinds blowing and this seems to be a self-mutilator to boot
Hit a 15 year low , Need to have a look at the debt levels and would imagine thats where some of this cash is going
 
US and UK property isn't so hot currently that $4 billion might sell for less than they hope , especially if the assets are not completed yet
 
Lendlease Group announced $480m sale of US Military Housing business.

Continued execution of the Company's announced strategy with agreement reached for the sale of the US Military Housing business for $480 (US$320)m, anticipated to deliver operating profit after tax (OPAT) of $105 to 120m in 1H FY2025.

i hold LLC
 
Lendlease completes new Asia Pacific life sciences Joint Venture with Warburg Pincus

Lendlease has today announced the completion of the sale of its life sciences interests in Asia to a 50/50 Joint Venture with Warburg Pincus, creating a specialist real estate platform focussed on the fast-growing life sciences sector in Asia Pacific.

The Joint Venture has been seeded with the transfer of Lendlease’s LINO interests, including Leaf1, a recently completed life sciences workplace in Yokohama, Japan, with new investors and additional capital to be brought onto the platform as it sources new investment opportunities.

The transaction is expected to contribute approximately $80m to FY25 Operating Profit after Tax2.

Quotes attributable to Tony Lombardo, Group CEO, Lendlease“The establishment of our new life sciences Joint Venture with Warburg Pincus, one of the world’s leading global investors, creates a highly attractive growth platform to complement our existing international investment capabilities and ambition.“

We have continued to make strong progress following our May strategy update, having announced $1.9 billion of transactions from our FY25 target of $2.8 billion.


As we further simplify the Group and recycle capital, we remain focussed on strengthening our balance sheet, returning capital to security holders and investing in our high return Australian operations.”


Further information can be found at the Lendlease media centre: https://www.lendlease.com

ENDS


i hold LLC
 
Top